Park Place Capital’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Buy
4,450
+1,173
+36% +$502K 0.34% 47
2025
Q4
$1.4M Sell
3,277
-337
-9% -$147K 0.29% 58
2025
Q3
$1.62M Buy
3,614
+114
+3% +$51.6K 0.34% 51
2025
Q2
$1.69M Sell
3,500
-72
-2% -$41K 0.39% 48
2025
Q1
$2.2M Buy
3,572
+1,486
+71% +$845K 0.6% 32
2024
Q4
$1.11M Buy
2,086
+522
+33% +$294K 0.31% 73
2024
Q3
$940K Buy
1,564
+484
+45% +$274K 0.27% 85
2024
Q2
$586K Buy
1,080
+680
+170% +$389K 0.19% 114
2024
Q1
$257K Buy
400
+351
+716% +$213K 0.09% 203
2023
Q4
$28.7K Hold
49
0.01% 481
2023
Q3
$25.5K Hold
49
0.01% 585
2023
Q2
$26.5K Hold
49
0.01% 601
2023
Q1
$26.4K Hold
49
0.01% 595
2022
Q4
$25K Buy
+49
New +$23.9K 0.01% 609

Other funds holding CHE

Park Place Capital's CHE Position: Q1 2026 in Review

Park Place Capital increased its Chemed (CHE) stake by 36% in Q1 2026, buying an estimated $502K and bringing the position to 4,450 shares worth $1.68M. The position accounts for 0.34% of the portfolio, ranked #47.

Park Place Capital first reported a position in CHE in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.2M in Q1 2025. 488 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Park Place Capital held 4,450 shares of Chemed worth $1.68M as of Q1 2026.
  • Park Place Capital bought 1,173 Chemed shares in Q1 2026, an estimated $502K.
  • Chemed made up 0.34% of Park Place Capital's portfolio in Q1 2026, its #47 holding.
  • Park Place Capital first reported a position in Chemed in Q4 2022 and has held it in 14 quarters since.
  • Park Place Capital's Chemed position peaked at $2.2M in Q1 2025.
  • 488 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.